Veterinary Dermatology

Papers
(The TQCC of Veterinary Dermatology is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
Advances in our understanding of canine atopic dermatitis39
Wound healing in animals: a review of physiology and clinical evaluation31
Clinical signs and diagnosis of feline atopic syndrome: detailed guidelines for a correct diagnosis29
Feline allergic diseases: introduction and proposed nomenclature23
Treatment of the feline atopic syndrome – a systematic review18
The effect of a mixed cannabidiol and cannabidiolic acid based oil on client‐owned dogs with atopic dermatitis17
Onset and duration of action of lokivetmab in a canine model of IL‐31 induced pruritus15
Treatment complexity and caregiver burden are linked in owners of dogs with allergic/atopic dermatitis14
Beneficial effect of oclacitinib in a case of feline pemphigus foliaceus14
Prolonged twice‐daily administration of oclacitinib for the control of canine atopic dermatitis: a retrospective study of 53 client‐owned atopic dogs13
Immunopathogenesis of the feline atopic syndrome12
A case report of the beneficial effect of oclacitinib in a dog with pemphigus vulgaris11
A masked, randomised clinical trial evaluating the efficacy and safety of lokivetmab compared to saline control in client‐owned dogs with allergic dermatitis10
Whole genome sequencing and de novo assembly of Staphylococcus pseudintermedius: a pangenome approach to unravelling pathogenesis of canine pyoderma10
Caregiver burden, treatment complexity, and the veterinarian–client relationship in owners of dog with skin disease9
Clinical Techniques: When and how to do a myringotomy – a practical guide9
Effective treatment of canine chronic cutaneous lupus erythematosus variants with oclacitinib: Seven cases9
Multivariable analysis of the influence of cross‐reactive carbohydrate determinant inhibition and other factors on intradermal and serological allergen test results: a prospective, multicentre study9
Malasseziaotitis unresponsive to primary care: outcome in 59 dogs8
In vitro antimicrobial activity of cold atmospheric microwave plasma against bacteria causing canine skin and ear infections8
A retrospective evaluation of the steroid sparing effects of oral mycophenolate mofetil (MMF) as an adjunct immunosuppressant for the treatment of canine pemphigus foliaceus8
Ichthyosis and hereditary cornification disorders in dogs8
Sensitivity and specificity of a shortened elimination diet protocol for the diagnosis of food‐induced atopic dermatitis (FIAD)8
Local wound management: A review of modern techniques and products8
Fatal disseminated toxoplasmosis in a feline immunodeficiency virus‐positive cat receiving oclacitinib for feline atopic skin syndrome8
Efficacy of subcutaneous allergen immunotherapy in atopic dogs: A retrospective study of 664 cases7
Characterization of canine epidermal organoid cultures by immunohistochemical analysis and quantitative PCR7
In vitro antibacterial and antibiofilm effects of cold atmospheric microwave plasma against Pseudomonas aeruginosa causing canine skin and ear infections7
Extensive progressive pigmented viral plaques in a Chihuahua dog7
The skin microbiota in equine pastern dermatitis: a case‐control study of horses in Switzerland7
Brachycephaly in French bulldogs and pugs is associated with narrow ear canals7
Immunomodulatory effect of long‐term oclacitinib maleate therapy in dogs with atopic dermatitis7
A novel therapeutic diet can significantly reduce the medication score and pruritus of dogs with atopic dermatitis during a nine‐month controlled study7
Effect of an anti‐inflammatory pomegranate otic treatment on the clinical evolution and microbiota profile of dogs with otitis externa7
Evaluation of skin erythema severity by dermatoscopy in dogs with atopic dermatitis6
The number of mitochondrial DNA mutations as a genetic feature for hair cycle arrest (alopecia X) in Pomeranian dogs6
Oral dexamethasone sodium phosphate solution significantly reduces pruritus and clinical lesions in feline hypersensitivity dermatitis: an open‐label study6
Epithelial–immune crosstalk with the skin microbiota in homeostasis and atopic dermatitis – a mini review6
Venom immunotherapy for Hymenoptera allergy in a dog6
The nose is not enough: Multi‐site sampling is best forMRSPdetection in dogs and households6
Is low‐level laser therapy useful as an adjunctive treatment for canine acral lick dermatitis? A randomized, double‐blinded, sham‐controlled study6
Furuncular myiasis caused by Dermatobiahominis in five cats and efficacy of topical fluralaner for its treatment6
IL‐31 and IL‐31 receptor expression in acute experimental canine atopic dermatitis skin lesions6
Efficacy and safety of 0.0584% hydrocortisone aceponate topical spray and systemic oclacitinib combination therapy in dogs with atopic dermatitis: a randomized, double‐blinded, placebo‐controlled tria6
Longitudinal study of the cutaneous microbiota of healthy horses6
Skin disease in goats (Capra aegagrus hircus): a retrospective study of 358 cases at a university veterinary teaching hospital (1988–2020)6
Cases of dermatophytosis caused by Trichophyton benhamiae var. luteum and T. europaeum, newly described dermatophytes within the T. benhamiae complex6
Trunk‐dominant and classic facial pemphigus foliaceus in dogs – comparison of anti‐desmocollin‐1 and anti‐desmoglein‐1 autoantibodies and clinical presentations6
Equine allergic skin diseases: Clinical consensus guidelines of the World Association for Veterinary Dermatology6
Grainyhead‐like transcription factors: guardians of the skin barrier6
Carbon dioxide laser surgery for chronic proliferative and obstructive otitis externa in 26 dogs5
A world of inflammation: the need for ecological solutions that co‐benefit people, place and planet5
Strain elastography for the assessment of skin nodules in dogs5
Veterinary allergy information has lower health readability than human allergy information: a comparative analysis of allergy education materials for pets and people5
Altered plasma cytokines in dogs with atopic dermatitis5
Influence of hospital size on antimicrobial resistance and advantages of restricting antimicrobial use based on cumulative antibiograms in dogs withStaphylococcuspseudintermediusinfectio5
Weekly topical therapy based on plant extracts combined with lokivetmab in canine atopic dermatitis5
Evaluation of cutaneous and circulating (serum and exosomes) levels of chemokines (CCL17, CCL22, CCL27 and CCL28) in atopic dogs and their correlation with 5
The upper epidermis of atopic dogs is altered at the functional and structural levels5
Canine pedal papilloma identification and management: a retrospective series of 44 cases5
Ear tip ulcerative dermatitis treated with oclacitinib in 25 dogs: a retrospective case series5
Use of oclacitinib as antipruritic drug during sarcoptic mange infestation treatment5
Clinical efficacy of sublingual allergen‐specific immunotherapy in 22 cats with atopic dermatitis5
Clinical efficacy of spray‐based heat‐treated lactobacilli in canine atopic dermatitis: a preliminary, open‐label, uncontrolled study5
Hyperkeratotic erythema multiforme variant in 17 dogs4
Effects of the clinical severity of disease and concomitant pyoderma on serum acute‐phase proteins concentrations in dogs with sarcoptic mange4
Treatment of canine cutaneous epitheliotropic T‐cell lymphoma with oclacitinib: a case report4
Combined prick and patch tests for diagnosis of food hypersensitivity in dogs with chronic pruritus4
Preliminary study of the stability of dexamethasone when added to commercial veterinary ear cleaners over a 90 day period4
The influence of clinical severity and topical antimicrobial treatment on bacteriological culture and the microbiota of equine pastern dermatitis4
Results of food challenge in dogs with cutaneous adverse food reactions4
Survey of cytokines on ocular surfaces of atopic dogs by multiplex analysis using two sampling methods – a pilot study4
Canine junctional epidermolysis bullosa due to a novel mutation in LAMA3 with severe upper respiratory involvement4
Transient and reversible reduction of stratum corneum filaggrin degradation products after allergen challenge in experimentally mite‐sensitised atopic dogs4
Preventive use of a topical anti‐inflammatory glucocorticoid in atopic dogs without clinical sign of otitis does not affect ear canal microbiota and mycobiota4
An international seroprevalence survey of the IgE sensitisation to the Dermatophagoides farinae house dust mite and two of its major allergens (Der f 2, Zen 1) in atopic dogs4
Cutaneous microRNA expression in healthy Labrador and Golden retrievers and retrievers with allergic and inflammatory skin diseases4
Bacteriophage therapy for challenging bacterial infections: achievements, limitations and prospects for future clinical use by veterinary dermatologists4
Preliminary evaluation of two bathing methods for the management of Malassezia overgrowth in dogs with atopic dermatitis4
Clinical presentation, treatment and outcome in dogs with pemphigus foliaceus with and without vasculopathic lesions: an evaluation of 41 cases4
Atopic dermatitis in West Highland white terriers – Part III: early life peripheral blood regulatory T cells are reduced in atopic dermatitis4
A randomised, double‐blinded comparison between subcutaneous rush and intralympathic allergen immunotherapy induction in atopic dogs4
Canine melanocytes: Immunohistochemical expression of melanocytic markers in different somatic areas4
Evidence‐base for the beneficial effect of nutraceuticals in canine dermatological immune‐mediated inflammatory diseases — A literature review4
Detection and inhibition of IgE antibodies reactive with cross‐reactive carbohydrate determinants in an ELISA for allergen‐specific IgE in horses4
The efficacy of subcutaneous slow‐release melatonin implants in the prevention of canine flank alopecia recurrence is uncertain: A double‐blind, randomized, placebo‐controlled study4
Staphylococci isolated from cats in Italy with superficial pyoderma and allergic dermatitis: Characterisation of isolates and their resistance to antimicrobials4
Evaluation of cold atmospheric microwave plasma on skin physiological parameters and tolerability in dogs4
Local treatment for canine anal sacculitis: A retrospective study of 33 dogs4
Regional alopecia and dermatitis due to Lodderomyces elongisporus in a North American porcupine (Erethizon dorsatum)3
The use of optical coherence tomography for skin evaluation in healthy rats3
Long‐term effects of ciclosporin and oclacitinib on mediators of tolerance, regulatory T‐cells, IL‐10 and TGF‐β, in dogs with atopic dermatitis3
Hair follicle dystrophy in a litter of domestic cats resembling lanceolate hair mutant mice3
Update on the skin barrier, cutaneous microbiome and host defence peptides in canine atopic dermatitis3
Evaluation of the effects of chlorhexidine digluconate with and without cBD103 or cCath against multidrug‐resistant clinical isolates of Staphylococcus pseudintermedius3
Allergen components of Dermatophagoides farinae recognised by serum immunoglobulin (Ig)E in Thai dogs with atopic dermatitis3
Persistent activation of the mammalian target of rapamycin signalling pathway in cutaneous squamous cell carcinomas in cats3
The efficacy of a novel topical spray composed of sodium benzoate, alcohol and botanical oils for the treatment of Malassezia dermatitis in dogs – a split body, randomised, blinded study3
Detection of a novel papillomaviral sequence in viral plaques confined to the pinna of a dog3
Alopecias in humans: biology, pathomechanisms and emerging therapies3
Determination of the efficacy rate and time‐to‐efficacy of subcutaneous immunotherapy in dogs with atopic dermatitis3
Retrospective case series: Necrotising fasciitis in 23 dogs3
Update on the role of cytokines and chemokines in canine atopic dermatitis3
Introduction to the ICADA 2023 canine atopic dermatitis pathogenesis review articles and updated definition3
A randomised controlled trial testing the rebound‐preventing benefit of four days of prednisolone during the induction of oclacitinib therapy in dogs with atopic dermatitis3
Detection of Microsporum canis and Trichophyton mentagrophytes by loop‐mediated isothermal amplification (LAMP) and real‐time quantitative PCR (qPCR) met3
A study into the fatty acid content of selected veterinary diets, supplements and fish oil capsules in Australia3
The effect of topical lidocaine on intradermal testing in atopic dogs3
Prevalence of serum immunoglobulin E against cross‐reactive carbohydrate determinants in allergic and nonallergic horses, and its impact on polysensitisation in serum allergen tests3
The usefulness of a hydrolysed fish and rice starch elimination diet for the diagnosis of adverse food reactions in cats: an open clinical trial3
A clinical retrospective study of Caparinia tripilis (Psoroptidae) mite dermatitis in pet African pygmy hedgehogs (Ateletrix albiventris) in southern Italy3
Determination of amikacin stability at 1% and 3% concentrations in four topical solutions over a 56‐day period3
A randomised, double‐blinded, controlled trial to determine the efficacy of combined therapy of oclacitinib and marine oil extract PCSO‐524 in dogs with atopic dermatitis3
Pseudomonas aeruginosa isolation from dog grooming products used by private owners or by professional pet grooming salons: prevalence and risk factors3
Transdermal drug delivery in horses: An in vitro comparison of skin structure and permeation of two model drugs at various anatomical sites3
The stability and in vitro antibacterial efficacy of enrofloxacin and gentamicin solutions against Staphylococcus pseudintermedius over 28 days3
0.20080995559692